Podocyte-Mediated Protection from Kidney Injury.

Autor: Lehtonen S; Department of Pathology, University of Helsinki, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland., Meri S; Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.

Publikováno v: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2024 Dec 27. Date of Electronic Publication: 2024 Dec 27.

Highly scalable and standardized organ-on-chip platform with TEER for biological barrier modeling.

Autor: Nguyen HT; Finnadvance Ltd, Oulu, Finland.; Faculty of Biochemistry and Molecular Medicine, and Biocenter Oulu, University of Oulu, Oulu, Finland., Rissanen SL; Finnadvance Ltd, Oulu, Finland., Peltokangas M; Finnadvance Ltd, Oulu, Finland., Laakkonen T; Finnadvance Ltd, Oulu, Finland., Kettunen J; Finnadvance Ltd, Oulu, Finland., Barthod L; Finnadvance Ltd, Oulu, Finland., Sivakumar R; Finnadvance Ltd, Oulu, Finland., Palojärvi A; Finnadvance Ltd, Oulu, Finland., Junttila P; Finnadvance Ltd, Oulu, Finland., Talvitie J; Finnadvance Ltd, Oulu, Finland., Bassis M; Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg., Nickels SL; Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg., Kalvala S; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Ilina P; Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Tammela P; Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Lehtonen S; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.; Neuroscience Center, University of Helsinki, Helsinki, Finland., Schwamborn JC; Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg., Mosser S; Finnadvance Ltd, Oulu, Finland., Singh P; Finnadvance Ltd, Oulu, Finland.

Publikováno v: Tissue barriers [Tissue Barriers] 2024 Oct; Vol. 12 (4), pp. 2315702. Date of Electronic Publication: 2024 Feb 12.

LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma.

Autor: Randén-Brady R; Department of Pathology, University of Helsinki, 00014, Helsinki, Finland. reija.randen-brady@hus.fi.; Department of Pathology, University of Helsinki and Helsinki University Hospital, 00290, Helsinki, Finland. reija.randen-brady@hus.fi., Carpén T; Department of Pathology, University of Helsinki, 00014, Helsinki, Finland.; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, and Helsinki University Hospital, 00029, Helsinki, Finland.; Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, 00014, Helsinki, Finland., Hautala LC; Research Program for Clinical and Molecular Metabolism, University of Helsinki, 00014, Helsinki, Finland., Tolvanen T; Department of Pathology, University of Helsinki, 00014, Helsinki, Finland., Haglund C; University of Helsinki, and Helsinki University Hospital, 00029, Helsinki, Finland., Joenväärä S; Transplantation Laboratory, Haartman Institute, University of Helsinki and Helsinki University Hospital, 00029, Helsinki, Finland.; HUS Diagnostic Center, Department of Pathology, HUSLAB, Helsinki University Hospital, 00029, Helsinki, Finland., Mattila P; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, and Helsinki University Hospital, 00029, Helsinki, Finland., Mäkitie A; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, and Helsinki University Hospital, 00029, Helsinki, Finland.; Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, 00014, Helsinki, Finland.; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institute and Karolinska Hospital, 171 76, Stockholm, Sweden., Lehtonen S; Department of Pathology, University of Helsinki, 00014, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, University of Helsinki, 00014, Helsinki, Finland., Hagström J; Department of Pathology, University of Helsinki, 00014, Helsinki, Finland.; Research Programs Unit, Translational Cancer Medicine, University of Helsinki, 00014, Helsinki, Finland.; Department of Oral Pathology and Oral Radiology, University of Turku, 20520, Turku, Finland.; Transplantation Laboratory, Haartman Institute, University of Helsinki and Helsinki University Hospital, 00029, Helsinki, Finland.; HUS Diagnostic Center, Department of Pathology, HUSLAB, Helsinki University Hospital, 00029, Helsinki, Finland., Silén S; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, and Helsinki University Hospital, 00029, Helsinki, Finland.; Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, 00014, Helsinki, Finland.

Publikováno v: Scientific reports [Sci Rep] 2024 Jun 19; Vol. 14 (1), pp. 14148. Date of Electronic Publication: 2024 Jun 19.

Evidence of overactivation in schizophrenia-derived microglia-like cells is present in tri-cultures but not mono-cultures

Autor: Hewitt, T. ¹, Bergroth, K. ¹, Jasikova, S. ¹, Koskuvi, M. ^{1, 2}, Pörsti, E. ¹, Räsänen, N. ¹, Trontti, K. ^{1, 3, 4}, Kalyanaraman, S. ¹, Hovatta, I. ^{1, 3, 4}, Lähteenvuo, M. ⁵, Rolova, T. ¹, Lehtonen, Š. ^{1, 6}, Tiihonen, J. ^{1, 7}, Koistinaho, J. ¹

Publikováno v: In Neuroscience Applied 2024 3 Supplement 2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.